Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

ASH

This page shows the latest ASH news and features for those working in and with pharma, biotech and healthcare.

ASH 2020: Gilead eyes new Yescarta indication, Vertex/CRISPR make headway in sickle cell and more

ASH 2020: Gilead eyes new Yescarta indication, Vertex/CRISPR make headway in sickle cell and more

A round-up of some of the key data from the annual American Society of Hematology (ASH) meeting. ... bluebird bio also posted long-term data for its own beta thalassaemia gene therapy Zynteglo (betibeglogene autotemcel) at ASH 2020.

Latest news

More from news
Approximately 13 fully matching, plus 67 partially matching documents found.

Latest Intelligence

  • Could coronavirus re-shape learning and development in pharma? Could coronavirus re-shape learning and development in pharma?

    By Yvonne Ash. No company could have planned for the impact of coronavirus on safeguarding employees while ensuring business continuity and the need to adapt to a virtual environment.We have ... Yvonne Ash is Vice President, Learning Solutions at Syneos

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    At this year’s American Society of Haematology (ASH) meeting, Allogene and partner Servier presented phase 1 data for their UCART19 candidate in ALL which revealed impressive response rates.

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    We’ll get that information or at least an early signal at the ASH congress in December.”.

  • Deal Watch November 2016 Deal Watch November 2016

    This is despite some positive news for Juno released at the recent ASH meeting that another of its CAR T cell therapeutics, JCAR017, showed a 60% complete response in patients with ... This does not typically include royalty payments. 2. Ataga et al,

  • Community pharmacy and OTC healthcare Community pharmacy and OTC healthcare

    Traditionally, the image of community pharmacists has been based on a transactional model - the supply and dispensing of medicines. The role of pharmacists has evolved considerably over the last decade and faces radical changes, as it moves towards

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Publicis Health UK bolsters leadership team Publicis Health UK bolsters leadership team

    Ash Kuchel, global group president of Publicis Health, said: “With her infectious passion and vision, Victoria was the perfect person for the job.

  • COUCH names Jenny McParland as account executive COUCH names Jenny McParland as account executive

    Ash Rishi, COUCH's managing director, said: “We are proud to welcome Jenny to our team and excited to introduce her to our range of healthcare accounts.

  • Two new hires at Couch Two new hires at Couch

    Ash Rishi, also co-managing director at Couch, said: “The fact that they both have industry experience is a huge plus, but their experience of working with big brands such as

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....

Quick links